HS, not sure what the emphasis on R&D line item is all about.
Not an accountant, so accountants are certainly free to correct me, but R&D is expensed as it occurs. What special treatment would SHMP receive for showing R&D as a separate line item?
It's not going to go to patent valuation. One could argue that everything SHMP does is R&D (pretty poor R&D if you ask me, considering SHMP either doesn't have or doesn't like whatever production numbers they managed to calculate).